title: Innovative Therapies against Human Glioblastoma Multiforme.
abstract: Glioblastoma multiforme is the most invasive and aggressive brain tumor in humans, and despite the latest chemical and radiative therapeutic approaches, it is still scarcely sensitive to these treatments and is generally considered an incurable disease. This paper will focus on the latest approaches to the treatment of this cancer, including the new chemicals such as proautophagic drugs and kinases inhibitors, and differentiating agents. In this field, there have been opening new perspectives as the discovery of possible specific targets such as the EGFRvIII, a truncated form of the EGF receptor. Antibodies against these targets can be used as proapoptotic agents and as possible carriers for chemicals, drugs, radioisotopes, and toxins. In this paper, we review the possible mechanism of action of these therapies, with particular attention to the combined use of toxic substances (for example, immunotoxins) and antiproliferative/differentiating compounds (i.e., ATRA, PPARγ agonists). All these aspects will be discussed in the view of progress clinical trials and of possible new approaches for directed drug formulations.
authors.affiliation: Department of Basic and Applied Biology, University of l'Aquila, Via Vetoio No. 10, 67010 L'Aquila, Italy.
authors.forename: Annamaria
authors.initials: A
authors.lastname: Cimini
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Ippoliti
references.citation: Genomics. 2001 Mar 1;72(2):217-21
references.pmid: 11401436
references.citation: Int J Cancer. 2005 Dec 20;117(6):923-33
references.pmid: 15986437
references.citation: Mol Cancer Res. 2006 Dec;4(12):927-34
references.pmid: 17189383
references.citation: Cell. 1998 Oct 2;95(1):29-39
references.pmid: 9778245
references.citation: J Neurosurg. 2008 Aug;109(2):268-72
references.pmid: 18671639
references.citation: J Neurooncol. 1999;44(3):243-53
references.pmid: 10720204
references.citation: Int J Cancer. 1998 May 18;76(4):547-51
references.pmid: 9590132
references.citation: J Neurovirol. 1998 Apr;4(2):148-58
references.pmid: 9584952
references.citation: J Clin Oncol. 1999 Aug;17(8):2572-8
references.pmid: 10561324
references.citation: Mol Cell Endocrinol. 1987 Jun;51(3):169-86
references.pmid: 3109978
references.citation: J Neurosurg. 1992 May;76(5):792-8
references.pmid: 1564542
references.citation: Oncologist. 2006 Feb;11(2):165-80
references.pmid: 16476837
references.citation: Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):860-8
references.pmid: 16467100
references.citation: Int J Oncol. 2009 Mar;34(3):717-27
references.pmid: 19212677
references.citation: Neurochem Res. 2007 Dec;32(12):2203-9
references.pmid: 17676389
references.citation: Cancer Immunol Immunother. 2008 Jan;57(1):115-21
references.pmid: 17634939
references.citation: J Clin Oncol. 2009 Oct 1;27(28):4733-40
references.pmid: 19720927
references.citation: Nature. 1985 Jan 10-18;313(5998):144-7
references.pmid: 2981413
references.citation: Neurosurgery. 2002 Jul;51(1):2-12; discussion 12-3
references.pmid: 12182418
references.citation: Ugeskr Laeger. 2006 Jun 12;168(24):2354-61
references.pmid: 16822420
references.citation: J Biol Chem. 2005 Oct 28;280(43):36228-36
references.pmid: 16085646
references.citation: Neurosurg Focus. 2006 Apr 15;20(4):E7
references.pmid: 16709038
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7727-31
references.pmid: 8052651
references.citation: Cancer Res. 2001 Nov 15;61(22):8058-61
references.pmid: 11719427
references.citation: Cancer Res. 2002 Jan 1;62(1):200-7
references.pmid: 11782378
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14720-5
references.pmid: 11121071
references.citation: Cancer Res. 1988 Mar 1;48(5):1233-7
references.pmid: 2963688
references.citation: Nat Rev Cancer. 2005 Sep;5(9):726-34
references.pmid: 16148885
references.citation: Neurochirurgie. 2010 Dec;56(6):491-8
references.pmid: 21035151
references.citation: J Neurosurg. 2003 Jan;98(1):154-61
references.pmid: 12546364
references.citation: Oncogene. 2007 Mar 22;26(13):1840-51
references.pmid: 17001313
references.citation: J Clin Oncol. 2010 Jun 10;28(17):2817-23
references.pmid: 20458050
references.citation: Cancer Treat Rev. 2002 Apr;28(2):115-20
references.pmid: 12297119
references.citation: Pathol Oncol Res. 2009 Jun;15(2):225-9
references.pmid: 18752056
references.citation: J Natl Cancer Inst. 2005 Jun 15;97(12):880-7
references.pmid: 15956649
references.citation: Clin Cancer Res. 2001 Feb;7(2):267-76
references.pmid: 11234878
references.citation: Cancer Res. 2004 Jan 15;64(2):696-703
references.pmid: 14744787
references.citation: Oncogene. 2005 Feb 3;24(6):980-91
references.pmid: 15592527
references.citation: Cell. 1995 Dec 15;83(6):835-9
references.pmid: 8521507
references.citation: Clin Cancer Res. 1999 Jun;5(6):1539-49
references.pmid: 10389943
references.citation: J Cell Physiol. 2008 Oct;217(1):93-102
references.pmid: 18446822
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14815-20
references.pmid: 8962138
references.citation: Cancer Metastasis Rev. 1988 Dec;7(4):347-56
references.pmid: 3061678
references.citation: PPAR Res. 2010;2010:427401
references.pmid: 20339586
references.citation: J Neurosurg. 2003 Dec;99(6):1047-52
references.pmid: 14705733
references.citation: J Biol Chem. 2002 Jun 21;277(25):22320-9
references.pmid: 11940602
references.citation: Proc Natl Acad Sci U S A. 1998 May 12;95(10):5724-9
references.pmid: 9576951
references.citation: Lancet. 2003 Jan 25;361(9354):323-31
references.pmid: 12559880
references.citation: N Engl J Med. 2005 Mar 10;352(10):997-1003
references.pmid: 15758010
references.citation: Rev Med Liege. 2008 May-Jun;63(5-6):251-6
references.pmid: 18669189
references.citation: J Cancer Res Clin Oncol. 2006 Sep;132(9):589-99
references.pmid: 16736141
references.citation: Bioconjug Chem. 2003 Nov-Dec;14(6):1107-14
references.pmid: 14624623
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5
references.pmid: 10200246
references.citation: Oncogene. 2004 Apr 12;23(16):2757-65
references.pmid: 15077139
references.citation: Oncogene. 2003 May 19;22(20):3152-61
references.pmid: 12789291
references.citation: Neurosurgery. 1999 Dec;45(6):1442-53
references.pmid: 10598712
references.citation: J Clin Oncol. 2004 Jan 1;22(1):133-42
references.pmid: 14638850
references.citation: J Exp Clin Cancer Res. 2009 Sep 29;28:133
references.pmid: 19788747
references.citation: Clin Cancer Res. 2000 Jul;6(7):2835-43
references.pmid: 10914732
references.citation: Cancer Cell. 2004 Sep;6(3):203-8
references.pmid: 15380510
references.citation: Cell. 2000 Oct 13;103(2):211-25
references.pmid: 11057895
references.citation: Cancer Res. 2001 Jan 15;61(2):439-44
references.pmid: 11212227
references.citation: Cancer Res. 2010 Aug 1;70(15):6303-12
references.pmid: 20647323
references.citation: Cancer Res. 2002 Feb 15;62(4):1087-92
references.pmid: 11861387
references.citation: Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2965-9
references.pmid: 1557402
references.citation: Int J Cancer. 2000 May 20;89(3):251-8
references.pmid: 10861501
references.citation: J Immunol. 1992 Mar 1;148(5):1404-10
references.pmid: 1538124
references.citation: Neuron. 2006 Jul 20;51(2):187-99
references.pmid: 16846854
references.citation: Adv Enzyme Regul. 2006;46:249-79
references.pmid: 16854453
references.citation: Curr Opin Oncol. 2007 Nov;19(6):598-605
references.pmid: 17906459
references.citation: Int J Cancer. 2000 Dec 15;88(6):962-9
references.pmid: 11093822
references.citation: Mol Cell. 1998 Feb;1(3):465-70
references.pmid: 9660931
references.citation: J Neurooncol. 2003 Oct;65(1):63-75
references.pmid: 14649886
references.citation: Protein Eng Des Sel. 2004 Feb;17(2):157-64
references.pmid: 15047912
references.citation: J Clin Oncol. 1998 Dec;16(12):3851-7
references.pmid: 9850030
references.citation: Neurosurg Clin N Am. 2010 Jan;21(1):87-93
references.pmid: 19944969
references.citation: Neuro Oncol. 2003 Apr;5(2):79-88
references.pmid: 12672279
references.citation: Mol Cancer Ther. 2002 Jul;1(9):707-17
references.pmid: 12479367
references.citation: Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1192-9
references.pmid: 16626884
references.citation: Oncogene. 1992 Jul;7(7):1355-9
references.pmid: 1320245
references.citation: Cancer Treat Rev. 2006 Apr;32(2):74-89
references.pmid: 16488082
references.citation: Int J Cancer. 2005 Jul 10;115(5):752-9
references.pmid: 15704175
references.citation: Hematol Oncol. 2004 Jun;22(2):63-71
references.pmid: 15468344
references.citation: J Neurooncol. 2011 Sep;104(2):509-22
references.pmid: 21336775
references.citation: Cancer Immunol Immunother. 2007 May;56(5):615-25
references.pmid: 16947022
references.citation: Clin Cancer Res. 1999 Oct;5(10 Suppl):3143s-3147s
references.pmid: 10541355
references.citation: Cancer Metastasis Rev. 1999;18(4):427-36
references.pmid: 10855786
references.citation: Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):91-6
references.pmid: 16540738
references.citation: Cell Death Differ. 2004 Apr;11(4):448-57
references.pmid: 14713959
references.citation: Int J Cancer. 2001 Apr 15;92(2):168-75
references.pmid: 11291041
references.citation: Cancer Res. 2006 Aug 15;66(16):8042-8
references.pmid: 16912180
references.citation: Eur J Pharmacol. 2009 Dec 25;625(1-3):23-30
references.pmid: 19836372
references.citation: Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):941-9
references.pmid: 14967454
references.citation: Neuro Oncol. 2006 Jan;8(1):67-78
references.pmid: 16443950
references.citation: Trends Mol Med. 2008 May;14(5):228-35
references.pmid: 18403264
references.citation: J Neurosci Res. 2003 Aug 1;73(3):341-50
references.pmid: 12868068
references.citation: Neurosurgery. 2002 Oct;51(4):1005-13; discussion 1013-4
references.pmid: 12234411
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6
references.pmid: 14711994
references.citation: Apoptosis. 2006 Sep;11(9):1503-12
references.pmid: 16820965
references.citation: Radiat Res. 2003 Aug;160(2):224-31
references.pmid: 12859234
references.citation: Cancer Res. 2002 Dec 15;62(24):7291-7
references.pmid: 12499272
references.citation: Nat Rev Neurosci. 2007 Aug;8(8):610-22
references.pmid: 17643088
references.citation: Cancer Res. 2004 Jun 15;64(12):4286-93
references.pmid: 15205343
references.citation: Urol Oncol. 2006 Sep-Oct;24(5):442-7
references.pmid: 16962497
references.citation: Clin Cancer Res. 2000 Jun;6(6):2157-65
references.pmid: 10873064
references.citation: Nat Rev Cancer. 2004 May;4(5):335-48
references.pmid: 15122205
references.citation: J Clin Oncol. 2006 Mar 10;24(8):1273-80
references.pmid: 16525182
references.citation: Curr Treat Options Neurol. 2010 Jul;12(4):321-33
references.pmid: 20842591
references.citation: Oncologist. 2008 Sep;13(9):933-44
references.pmid: 18784157
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2411-22
references.pmid: 15800333
references.citation: Eur J Clin Invest. 2002 Mar;32 Suppl 1:61-9
references.pmid: 11886434
references.citation: J Neurooncol. 2006 Jan;76(1):23-30
references.pmid: 16155724
references.citation: J Biol Chem. 1998 Jan 2;273(1):200-6
references.pmid: 9417065
references.citation: Cell Growth Differ. 1995 Oct;6(10):1251-9
references.pmid: 8845302
references.citation: Histol Histopathol. 2003 Jul;18(3):715-26
references.pmid: 12792883
references.citation: Nature. 1992 Oct 29;359(6398):845-8
references.pmid: 1279432
references.citation: Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):237-41
references.pmid: 8990192
references.citation: Int J Cancer. 1996 Jul 17;67(2):248-55
references.pmid: 8760595
references.citation: Cancer Res. 2007 Sep 15;67(18):8736-41
references.pmid: 17875714
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18030-5
references.pmid: 15596714
references.citation: Nat Rev Cancer. 2004 Aug;4(8):592-603
references.pmid: 15286739
references.citation: Anal Quant Cytol Histol. 2005 Apr;27(2):71-8
references.pmid: 15913199
references.citation: Clin Cancer Res. 2006 Dec 15;12(24):7261-70
references.pmid: 17189397
references.citation: Genes Dev. 2007 Jan 1;21(1):98-111
references.pmid: 17210792
references.citation: Med Hypotheses. 2000 Sep;55(3):187-8
references.pmid: 10985906
references.citation: J Biol Regul Homeost Agents. 1999 Apr-Jun;13(2):115-22
references.pmid: 10503735
references.citation: Cancer Res. 1988 Apr 15;48(8):2231-8
references.pmid: 3258189
references.citation: Clin Cancer Res. 1995 Nov;1(11):1253-8
references.pmid: 9815919
references.citation: Oncologist. 2007 Dec;12(12):1395-403
references.pmid: 18165616
references.citation: J Neuroimmunol. 1997 Sep;78(1-2):34-46
references.pmid: 9307226
references.citation: J Cell Sci. 2003 Nov 1;116(Pt 21):4409-17
references.pmid: 13130092
references.citation: Domest Anim Endocrinol. 2002 Mar;22(1):1-23
references.pmid: 11900961
references.citation: Am J Obstet Gynecol. 1998 Oct;179(4):1020-5
references.pmid: 9790391
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7866-71
references.pmid: 12060733
references.citation: Biochem Biophys Res Commun. 2005 Nov 11;337(1):52-60
references.pmid: 16185655
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: Mol Pharmacol. 2006 Sep;70(3):1045-52
references.pmid: 16782806
references.citation: Oncogene. 1999 Mar 4;18(9):1711-21
references.pmid: 10208432
references.citation: J Biol Chem. 1998 Jan 30;273(5):2817-22
references.pmid: 9446590
references.citation: J Biol Chem. 1996 Oct 11;271(41):25639-45
references.pmid: 8810340
references.citation: Cancer Res. 2002 Jul 1;62(13):3729-35
references.pmid: 12097282
references.citation: Oncogene. 2006 Nov 30;25(56):7333-5
references.pmid: 16785986